Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

Prophylactic dosing adjustment in pregnancy based upon measurements of anti-factor Xa levels.

Gyamfi C, Cohen R, Desancho MT, Gaddipati S.

J Matern Fetal Neonatal Med. 2005 Nov;18(5):329-31.

PMID:
16390793
[PubMed - indexed for MEDLINE]
2.

Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.

Shapiro NL, Kominiarek MA, Nutescu EA, Chevalier AB, Hibbard JU.

Pharmacotherapy. 2011 Jul;31(7):678-85. doi: 10.1592/phco.31.7.678.

PMID:
21923455
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.

PMID:
18574280
[PubMed - indexed for MEDLINE]
4.

Inherited thrombophilias and anticoagulation in pregnancy.

Bowles L, Cohen H.

Best Pract Res Clin Obstet Gynaecol. 2003 Jun;17(3):471-89. Review.

PMID:
12787539
[PubMed - indexed for MEDLINE]
5.

Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism.

Wilson SJ, Wilbur K, Burton E, Anderson DR.

Haemostasis. 2001 Jan-Feb;31(1):42-8.

PMID:
11408748
[PubMed - indexed for MEDLINE]
6.

Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study.

Norris LA, Bonnar J, Smith MP, Steer PJ, Savidge G.

Thromb Haemost. 2004 Oct;92(4):791-6.

PMID:
15467910
[PubMed - indexed for MEDLINE]
7.

Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.

Clark NP, Delate T, Cleary SJ, Witt DM.

Thromb Res. 2010 May;125(5):402-5. doi: 10.1016/j.thromres.2009.07.014. Epub 2009 Aug 21.

PMID:
19699510
[PubMed - indexed for MEDLINE]
8.

Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.

Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A.

Obstet Gynecol. 2008 Oct;112(4):884-9. doi: 10.1097/AOG.0b013e31818638dc. Erratum in: Obstet Gynecol. 2009 Mar;113(3):742.

PMID:
18827132
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.

Ní Ainle F, Wong A, Appleby N, Byrne B, Regan C, Hassan T, Milner M, Sullivan AO, White B, O'Donnell J.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):689-92. doi: 10.1097/MBC.0b013e32830b14ef.

PMID:
18832911
[PubMed - indexed for MEDLINE]
10.

Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant.

Michaels LA, Gurian M, Hegyi T, Drachtman RA.

Pediatrics. 2004 Sep;114(3):703-7.

PMID:
15342842
[PubMed - indexed for MEDLINE]
11.

Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy.

Oran B, Lee-Parritz A, Ansell J.

Thromb Haemost. 2004 Oct;92(4):747-51.

PMID:
15467905
[PubMed - indexed for MEDLINE]
12.

Anticoagulation in special patient populations: are special dosing considerations required?

Michota F, Merli G.

Cleve Clin J Med. 2005 Apr;72 Suppl 1:S37-42. Review.

PMID:
15853178
[PubMed - indexed for MEDLINE]
Free Article
13.

The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.

Abou-Nassar K, Kovacs MJ, Kahn SR, Wells P, Doucette S, Ramsay T, Clement AM, Khurana R, Mackinnon K, Blostein M, Solymoss S, Kingdom J, Sermer M, Rey E, Rodger M; TIPPS investigators.

Thromb Haemost. 2007 Jul;98(1):163-71.

PMID:
17598009
[PubMed - indexed for MEDLINE]
14.

Thromboembolic prophylaxis with low molecular weight heparin during pregnancy.

Rasmussen C, Wadt J, Jacobsen B.

Int J Gynaecol Obstet. 1994 Nov;47(2):121-5.

PMID:
7843480
[PubMed - indexed for MEDLINE]
15.

How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.

Hammerstingl C, Omran H, Tripp C, Poetzsch B.

Thromb Haemost. 2009 Feb;101(2):325-32.

PMID:
19190817
[PubMed - indexed for MEDLINE]
16.

[Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients].

Pavlović S, Zivković S, Koraćević G.

Vojnosanit Pregl. 2007 Aug;64(8):538-42. Serbian.

PMID:
17874721
[PubMed - indexed for MEDLINE]
17.

Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.

Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A.

Thromb Res. 2009 Jul;124(3):262-7. doi: 10.1016/j.thromres.2008.12.005. Epub 2009 Jan 21.

PMID:
19162303
[PubMed - indexed for MEDLINE]
18.

Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Lim W, Dentali F, Eikelboom JW, Crowther MA.

Ann Intern Med. 2006 May 2;144(9):673-84.

PMID:
16670137
[PubMed - indexed for MEDLINE]
19.

Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.

Bauman ME, Black KL, Bauman ML, Belletrutti M, Bajzar L, Massicotte MP.

Thromb Res. 2009 Apr;123(6):845-7. doi: 10.1016/j.thromres.2008.09.001. Epub 2008 Nov 26.

PMID:
19038418
[PubMed - indexed for MEDLINE]
20.

A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation.

Barbour LA, Oja JL, Schultz LK.

Am J Obstet Gynecol. 2004 Sep;191(3):1024-9.

PMID:
15467584
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk